Sponsored content brought to you by

NanoString logo

Understanding tissue heterogeneity is critical to answering key biological questions in human health and disease. Single-cell RNA sequencing can detect cellular heterogeneity but lacks the spatial context needed to understand the relationship of cell types to disease pathology. The newly available GeoMx Whole Transcriptome Atlas (WTA) accelerates scientific discovery by resolving tissue heterogeneity and the true molecular basis of disease that bulk RNA sequencing may easily miss.

The GeoMx WTA provides high-throughput, reproducible spatial analysis of any target in any tissue. The superior sensitivity of the GeoMx WTA enables the integration of single-cell datasets to pinpoint the location of cells and signatures critical to understanding disease mechanisms. With the GeoMx WTA you can comprehensively profile low-, medium-, and high-expressing genes without 3’ poly A bias on a wide range of sample types including FFPE, fresh frozen, and fixed frozen tissues with standard pathology workflows.


Learn how the revolutionary GeoMx Whole Transcriptome Atlas combines the power of
transcriptome analysis and tissue imaging to unlock spatial heterogeneity of disease,
Visit nanostring.com/GeoMxWTA

Previous articleThe Importance of CDMO Flexibility in AAV Manufacturing
Next articleFunctional Profiling of CRISPR-Edited Cells Identifies Potent and Durable Immune Therapies